Cosmeceutical peptides target skin aging, pigmentation, and barrier function. Argireline (acetyl hexapeptide-3, EEMQRR) inhibits SNARE complex assembly to reduce muscle contraction - a topical alternative to botulinum toxin. Decapeptide-12 (YRSRKYSSWY) is a patented tyrosinase inhibitor for skin lightening.
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a tripeptide that stimulates collagen synthesis and wound healing. The peptide sequence GHK is the minimal active unit; copper chelation enhances activity.
Groups peptides by what they do, not what they bind. There's no PDB or UniProt — the target is a function, not a molecule. For receptor-level structure, open a molecular target like GHSR.
EEMQRR · 6 aa · @peptidemodel
| # | id | title | author | status | refs | ipSAE_d0chn | ♥ |
|---|---|---|---|---|---|---|---|
| 1 | pep-00009 | GHK: natural skin-repair peptide (copper-binding, found in human blood) | pe@peptidemodel | 3 | — | 0 | |
| 2 | pep-00014 | Argireline: topical anti-wrinkle cosmetic peptide (acetyl hexapeptide-3) | pe@peptidemodel | 2 | — | 0 | |
| 3 | pep-00015 | Decapeptide-12: Lumixyl skin-brightening peptide | pe@peptidemodel | 1 | — | 0 |
No discussion threads yet.